78.02MMarket Cap11.54P/E (TTM)
4.780High4.440Low134.33KVolume4.670Open4.770Pre Close621.03KTurnover0.99%Turnover Ratio11.54P/E (Static)16.50MShares9.32952wk High1.40P/B64.17MFloat Cap3.09052wk Low--Dividend TTM13.57MShs Float15.250Historical High--Div YieldTTM7.13%Amplitude1.760Historical Low4.623Avg Price1Lot Size
Sensus Healthcare Stock Forum
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
Tuesday, 4th March at 8:00 am
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the publication of a study titled "Keloid Excision W...
Sensus Healthcare Resumes $3M Share Repurchase Program
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
Shipped a record 39 SRT systems during the quarter; revenues of $13.1 million
Achieved fifth consecutive quarter of profitability; diluted EPS of $0.09
Conference call begins at 4:30 p.m. Eastern time today
Positive
Record quarterly shipments of 39 SRT systems in Q4 2024
71% year-over-year revenue growth to $41.8 million
Fifth consecutive quarter of profitability
Strong cash position of...
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
Positive
Revenue increased 127% year-over-year to $8.8 million
Achieved net income of $1.2 million vs net loss of $1.5 million in prior year
Shipped 27 systems vs 11 systems in prior year quarter
Gross profit margin improved to 59.3% from 51.0%
Strong cash position of $22.6 million with no debt
Secured agreement with 130-clinic network Plat...
No comment yet